Nucleai and Propath UK announce partnership for end-to-end AI-powered spatial analysis of a 30-plex immunofluorescence immuno-oncology panel
Combining the power of spatial biology and AI, Propath and Nucleai push the boundaries of pathology tissue analytics to develop a novel, high multiplexed immunofluorescence (IF) panel and associated AI-powered algorithm for biomarker discovery and development HEREFORD, United Kingdom & TEL AVIV, Israel–(BUSINESS WIRE)–#aipowered—Propath UK, Europe’s leading CRO for spatial biology, and Nucleai, a leader … [Read more…]
